TRLV NYSE
Trulieve Cannabis Corp.
1W: -12.4%
1M: -8.5%
3M: +21.3%
YTD: +26.8%
$10.72
-0.15 (-1.38%)
Weekly Expected Move ±9.2%
$9
$10
$11
$12
$13
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
0.00
Neutral
0 bullish
0 neutral
0 bearish
Articles (24h)
0
No articles in the last 24 hours
0.00
Neutral
1 bullish
1 neutral
1 bearish
Articles (7d)
3
Daily Sentiment (7 Days)
Articles (17)
2 High-Octane Cannabis Stocks to Buy in October for Aggressive Investors
Cannabis stocks sink after DEA marijuana rescheduling hearing paused
DEA marijuana rescheduling hearing halted over GAO report
2 Cannabis Stocks That Are Quietly Trouncing the Market in 2026
Federal court allows Trump administration marijuana rescheduling to proceed
Most and least shorted mid- to mega-cap healthcare stocks at the end of August
Trulieve Cannabis Non-GAAP EPS of $0.11 beats by $0.08, revenue of $271M beats by $2.12M
Virginia and Texas Are About to Become Cannabis Battlegrounds. Here's Which Stocks Are Positioned to Win.
Should You Buy, Hold or Sell GTBIF Stock Post Q2 Earnings Release?
Better Cannabis Growth Stock: Trulieve or Vireo Growth
Trulieve CEO Sells $1.2 Million in Stock as Shares Jump 148% in One Year
Trulieve's NYSE Listing Is Historic. But Is the Stock Still Worth Buying?
GTBIF Stock Climbs 17.5% in Three Months: Time to Invest or Cash Out?
The Marijuana Industry Just Had a Massive Milestone
Tilray's Stock Is Down 45% This Year, and Here's Why It Could Still Go Lower
The First U.S. Marijuana Stock Is Now Trading on the NYSE. Here's What That Means for Every Cannabis Investor.
Trulieve Makes History As First US Cannabis Stock On NYSE